Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR
嵌合单克隆抗体 806 (ch806) 的工程设计和表征，用于针对表达 de2-7 EGFR 或扩增 EGFR 的肿瘤进行靶向免疫治疗
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/sj.bjc.6602470
C Panousis, V M Rayzman, T G Johns, C Renner, Z Liu, G Cartwright, F-T Lee, D Wang, H Gan, D Cao, A Kypridis, F E Smyth, M W Brechbiel, A W Burgess, L J Old, A M Scott
